Clinical Trial Update: Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy. [Phase 3]

View source ↗

Summary

Amgen reports the completion of a Phase 3 trial evaluating a treatment for anemia in patients with non-myeloid malignancies receiving multicycle chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia

Snippet

Sponsor: Amgen | Conditions: Anemia | Phase 3 | Status: COMPLETED